Parabilis Medicines, Inc. (PBLS)
Stock-Based Compensation
$8.50M
TTM · Period ending: · USD

PBLS Stock-Based Compensation
What is stock-based compensation?
Non-cash compensation expense paid in equity.
PBLS stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,317,000 | |
| 4,310,000 |
Frequently asked questions: PBLS stock-based compensation
What is Parabilis Medicines, Inc. (PBLS)'s current stock-based compensation?
Parabilis Medicines, Inc. (PBLS)'s latest reported stock-based compensation (TTM) is $8.50M as of Sep 30, 2026. Non-cash compensation expense paid in equity.
How much historical stock-based compensation data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s stock-based compensation, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's stock-based compensation to peers or set an alert?
You can open PBLS's stock-based compensation in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance